Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Leptospermum petersonii extract is a natural product derived from the lemon-scented teatree, a plant native to Australia. Research presented at the AACR 2026 meeting investigated its methanolic and ethyl acetate crude extracts for potential antineoplastic and antimetastatic properties. In vitro studies on pancreatic (MIA PaCa-2) and prostate (PC3) cancer cells demonstrated that the methanolic extract induces apoptosis, characterized by Caspase 3/7 activation and DNA fragmentation. The extract's mechanism of action involves the upregulation of the RB1 tumor suppressor and Checkpoint kinase 1 (CHEK1), leading to cell cycle arrest and DNA damage-induced programmed cell death. It also exhibits inhibitory effects on cell migration, suggesting antimetastatic potential.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on leptospermum petersonii extract.